Role of myeloperoxidase in patients with chronic kidney disease

B Kisic, D Miric, I Dragojevic, J Rasic… - … medicine and cellular …, 2016 - Wiley Online Library
Chronic kidney disease (CKD) is a worldwide public health problem. Patients with CKD
have a number of disorders in the organism, and the presence of oxidative stress and …

Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicability

L D'Marco, A Bellasi, P Raggi - Disease markers, 2015 - Wiley Online Library
The high incidence of cardiovascular events in chronic kidney disease (CKD) warrants an
accurate evaluation of risk aimed at reducing the burden of disease and its consequences …

Diminished antioxidant activity of high‐density lipoprotein–associated proteins in chronic kidney disease

DJ Kennedy, WH Wilson Tang, Y Fan… - Journal of the …, 2017 - Am Heart Assoc
Background Decreased serum arylesterase activity, catalyzed by the high‐density
lipoprotein–associated paraoxonase (PON)‐1, is associated with increased oxidant stress …

Paraoxonase 1 in chronic kidney failure

A Gugliucci, K Kotani, S Kimura - Journal of Lipids, 2012 - Wiley Online Library
In this review we summarize the findings from the literature and our own laboratory on the
decreased PON1 activity in renal failure, the mechanisms proposed and the effect of …

[HTML][HTML] Paraoxonase 1 and chronic kidney disease: a meta-analysis

J Watanabe, K Kotani, A Gugliucci - Journal of Clinical Medicine, 2023 - mdpi.com
Oxidative stress is known to be associated with the pathophysiology of chronic kidney
disease (CKD). Paraoxonase 1 (PON1) is an antioxidant enzyme that has been proposed as …

Determinants of paraoxonase 1 status: genes, drugs and nutrition

C Schrader, G Rimbach - Current medicinal chemistry, 2011 - ingentaconnect.com
Paraoxonase 1 (PON1) is an enzyme which is mainly synthesized in the liver. PON1
circulates in the blood bound to HDL and delays or prevents the oxidation of LDL. Single …

[HTML][HTML] Altered HDL proteome predicts incident CVD in chronic kidney disease patients

B Shao, AV Mathew, C Thornock, S Pennathur… - Journal of Lipid …, 2021 - ASBMB
Patients with chronic kidney disease (CKD) are at high risk for CVD. However, traditional
lipid risk factors, including low HDL levels, cannot completely explain the increased risk …

Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial

MM Sagheb, B Dormanesh, MK Fallahzadeh, H Akbari… - Sleep medicine, 2012 - Elsevier
BACKGROUND: Restless legs syndrome (RLS) is a common disorder in hemodialysis
patients that leads to insomnia and impaired quality of life. Because high oxidative stress …

Oxidative stress and autonomic nervous system functions in restless legs syndrome

MA Cikrikcioglu, M Hursitoglu, H Erkal… - European journal of …, 2011 - Wiley Online Library
Eur J Clin Invest 2011; 41 (7): 734–742 Abstract Background Oxidative stress has been
implicated in over 100 disorders in recent years; however, the situation in restless legs …

[HTML][HTML] Paraoxonase 1 activity and renal replacement therapy for chronic renal failure: a meta-analysis

J Watanabe, K Kotani, Y Iwazu, A Gugliucci - Journal of Clinical Medicine, 2023 - mdpi.com
Chronic renal failure (CRF) is associated with the development of cardiovascular disease
(CVD). Paraoxonase 1 (PON1), an antioxidant enzyme, shows cardioprotective properties …